KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

KALAMAZOO, MI -- Scientists at Western Michigan University Homer Stryker School of Medicine (WMed) have made a ...

Using a handheld dynamometer to assess hip flexion and abduction strength during dialysis was reliable and safe, researchers found in a cross-sectional study.“Subjects in stages 3 and 4 of [chronic ...

In an indication that has proved difficult for biopharma to conquer, Regulus Therapeutics Inc. disclosed further positive data from its ongoing phase Ib study testing RGLS-8429 in autosomal dominant ...

A research team at Western Michigan University Homer Stryker M.D. School of Medicine has made a significant discovery.

A team of researchers at Western Michigan University's Homer Stryker M.D. School of Medicine has made a monumental ...

(RTTNews) - Regulus Therapeutics Inc. (RGLS) Wednesday announced positive clinical as well as regulatory updates from its autosomal dominant polycystic kidney disease (ADPKD) program.

The case was a tricky one, a surgery was inevitable. The patient had lost a lot of blood. He was also in severe pain. Then, ...

XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA), a late stage clinical ...

The team, led by Erik Larson, PhD, published results explaining how Autosomal Dominant Polycystic Kidney Disease (ADPKD) is caused, a common kidney disease considered incurable. ADPKD is lethal ...

The complex nephrectomy was followed by a kidney transplant. The patient was discharged three days after the surgery and is ...

Jason Yondura’s cellphone rings, and the caller has a number he doesn’t recognize. Though it’s most likely a spam call, ...